Why Is B12 Prescribed To Patients With Multiple Sclerosis?

Featured Health Expert
19065
EXPERT

New Drug Ampyra Approved by FDA for Multiple Sclerosis Patients

Late Friday afternoon, January 22, 2010, the Food and Drug Administration (FDA) announced that they approved AMPYRA™ (dalfampridine, formerly known as fampridine-SR) as a treatment to improve walking in multiple sclerosis patients.  Developed by Acorda Therapeutics in partnership with Elan Corp, AMPYRA™ is a proprietary slow-release formulation of the compounded drug 4-aminopyridine (4-AP).

 

Although the name AMPYRA™ only hit the internet on Friday, the drug and its predecessor...

Read more

More information on "Why Is B12 Prescribed To Patients With Multiple Sclerosis?"

From Our Experts

See more SharePosts »

From Our Sources

More on Multiple Sclerosis »

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (1955) >